Literature DB >> 6792432

Prostaglandins and host defense in cancer.

J S Goodwin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6792432     DOI: 10.1016/s0025-7125(16)31500-0

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


× No keyword cloud information.
  6 in total

1.  Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis.

Authors:  O Gallo; A Franchi; L Magnelli; I Sardi; A Vannacci; V Boddi; V Chiarugi; E Masini
Journal:  Neoplasia       Date:  2001 Jan-Feb       Impact factor: 5.715

2.  Prognostic value of prostaglandin F2 alpha concentrations in breast carcinoma.

Authors:  P A van Dam; I B Vergote; G M Laekeman; G H Keersmaeckers; F L Uyttenbroeck; A G Herman
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

3.  Immunoregulatory effects of indomethacin on rats with trauma.

Authors:  Y C Pan; S X Zhang; X Z Ding; H Li
Journal:  J Tongji Med Univ       Date:  1995

4.  Alternation of monocyte function in patients with obstructive jaundice.

Authors:  X Z Ding; S T Xiong; H Li; S X Zhang; K Z Lü
Journal:  J Tongji Med Univ       Date:  1995

5.  Non-steroidol anti-inflammatory drug effect on crypt cell proliferation and apoptosis during initiation of rat colon carcinogenesis.

Authors:  C J Barnes; I L Cameron; W E Hardman; M Lee
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

6.  Prostaglandin F2 alpha in benign and malignant breast tumours.

Authors:  I B Vergote; G M Laekeman; G H Keersmaekers; F L Uyttenbroeck; J S Vanderheyden; G P Albertyn; C F Haensch; G J De Roy; A G Herman
Journal:  Br J Cancer       Date:  1985-06       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.